625 Howe Street
Suite 1200
Vancouver, BC V6C 2M6
Canada
808 650 3007
https://www.abattis.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Robert J. Abenante BBA, CA, MPAcc | President, CEO & Director | 274,85k | N/D | 1983 |
Mr. Francesco Paolini | CFO & Director | N/D | N/D | N/D |
Mr. Patrick Mitchell | COO & Director | N/D | N/D | N/D |
Mr. Shawn Balaghi | Head of Corporate Development | N/D | N/D | N/D |
Mr. Jim Carter | Head of Mergers and Acquisitions Advisory | N/D | N/D | N/D |
Mr. Christopher P. Cherry C.A., CPA, CA, CGA, CPA | Corporate Comptroller | N/D | N/D | 1979 |
Ms. Nicole Breitinger | Corporate Secretary | N/D | N/D | N/D |
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
L'ISS Governance QualityScore di Abattis Bioceuticals Corp. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.